dokumendiregister.ee
OtsingAsutusedMCP
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel
Otsing›Ravimiamet
Sissetulev kiriAvalik

Järelepärimine

Ravimiamet · 2. juuli 2024
Viit
ML-1/2366-1
Registreeritud
2. juuli 2024
Dokumendi liik
Sissetulev kiri
Adressaat
Põllumajandus- ja Toiduamet
Saabumis/saatmisviis
e-post
Funktsioon
ML Ravimite müügiload ja dokumentatsiooni hindamine
Sari
ML-1 Kirjavahetus ravimite teemal
Toimik
ML-1/2024
Vastutaja
Epp Ülevaino (RA, Müügilubade osakond, Kliinilise hindamise büroo)
Lahendamise tähtaeg
23. juuni 2024

Failid

  • 📎8. Future options for varroa control - WP Honey 21 November 23.pdf425 KB
  • 📎E-kiri.eml2354 KB
  • 📎Evaluering AHL 20240403.pdf156 KB
  • 📎Presentation Varroa NBBC 2024.pdf1130 KB

Sisu (failidest)

Saatja: "Kärolin Jenas" <[email protected]> Teema: FW: Orgaaniliste hapete kasutamine meemesilastel Varroa spp. lesta tõrjumisel Kuupäev: 2024-07-02 09:50 From: Kärt Jaarma <[email protected]> Sent: reede, 24. mai 2024 11:57 To: Epp Ülevaino <[email protected]> Cc: Anne-Ly Veetamm <[email protected]>; Olev Kalda <[email protected]> Subject: Orgaaniliste hapete kasutamine meemesilastel Varroa spp. lesta tõrjumisel Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Tere Rääkisin Pärnus veterinaararstide infopäeval põgusalt, et mesinikel on mure, et orgaanilisi happeid (nt oblikhape, sipelghape) ei tohi enam meemesilastel Varroa spp. lesta tõrjumisel kasutada. Nüüd pöördus üks mesinik PTA poole sama murega ja edastas ka Taani materjalid (kirjale lisatud), kus on kirjas, miks orgaanilisi happeid ei ole lubatud enam lesta tõrjumiseks kasutada. Saadetud materjalide alusel soovin ma teada Ravimiameti arvamust, kas me peaksime keelama orgaaniliste hapete kasutamise meemesilastel Varroa spp. lesta tõrjumisel, sest orgaanilised happed ei ole veterinaarravimid? Lugupidamisega Kärt Jaarma Peaspetsialist Loomatervise ja –heaolu osakond Põllumajandus- ja Toiduamet ______________________________ <mailto:[email protected]> [email protected] +372 5693 9141 Väike-Paala 3 / 11415 Tallinn/ <https://pta.agri.ee/> https://pta.agri.ee/ TÄHELEPANU *** See e-kiri (kaasa arvatud manused) on mõeldud ainult e-kirja adressaatidele ning võib sisaldada ametialaseks kasutamiseks ettenähtud teavet. Teavet ei tohi ilma saatja selgelt väljendatud loata edasi saata ega mistahes viisil kõrvalistele isikutele avaldada. Juhul, kui Te olete saanud käesoleva e-kirja eksituse tõttu, palun teavitage sellest kohe saatjat ning kustutage e-kiri oma arvutist. ATTENTION *** This e-mail and its attachments may contain official information. If you are not the intended recipient, please notify the sender immediately, delete this e-mail and destroy any copies. Any dissemination or use of this information by a person other than the intended recipient is unauthorized and may be unlawful. The Danish Beekeepers Association FUTURE OPTIONS FOR VARROA CONTROL Danish beekeepers have a long tradition of varroa control using organic acids in pure form following the regulation for organic beekeeping. This practice has been developed over 30 years and introduced to all beekeepers. The experience shows that this practice works well for beekeepers and bees. Beekeepers in several European countries seem to prefer a practice where organic acids can be used in pure form. With reference to dialog with DG Sante and Regulation 2019/6 new veterinary regulation (NVR), the Danish Food Authorities has announced that all treatment of varroa in the future must only be carried out with registered veterinary medicines (appendix 1) The challenges of the new regulation are: • There may be a shift towards more use of synthetic pesticides in beekeeping. • Varroa control is complicated as multiple treatments are needed over the season and each treatment must be adapted to the specific beekeeper management and the environmental conditions at the time of treatment. Experience says that we need a varroa strategy, not just individual treatments. • Only very few products based on organic acids are registered and cannot stand alone. • Several products have not been tested in Denmark. Furthermore, the instructions are not adapted to Danish conditions and beehives. Even with the ideal varroa strategy, beekeepers lose colonies every year due to Varroa problems. If treatment options are reduced, increased colony losses must be expected. On this background we strongly recommend that the possibilities for continued use of organic acids in pure form in beekeeping should be investigated. The following conditions must be noted: • Not all transmissible animal diseases can or should be prevented and controlled through regulatory measures, for example if the disease is too widespread, if diagnostic tools are not available, or if the private sector can take measures to control the disease by itself (appendix 2) • The ecology regulation states that varroa control with organic acids is only healthcare. If treated with chemically produced allopathic products, the conversion period of 12 months applies (appendix 3) We kindly request to WP-honey to: a) sharing information about the practice (implementation of the EU regulation) of availability and use of organic varrocides in other member states b) support for changing the interpretation or scope of the legislation in place. Rune Havgaard Sørensen Head of Secretariat Danish Beekeepers Association Fulbyvej 15 - DK-4180 Sorø www.biavl.dk [email protected] Cell. +45 51 30 72 06 Appendix 1: Fra: [email protected] <[email protected]> Sendt: 5. oktober 2023 16:27 Til: Anne Rath Petersen <[email protected]> Cc: Christian Strøyer <[email protected]>; [email protected]; SANTE-VETERINARY- [email protected] Emne: RE: VMP - treatment of Varroa destructor in honey bees Dear Dr Rath Petersen, We are sorry for the delay in replying to your question. A substance presented as having properties for treating a disease, like varroosis, would meet the definition of ‘veterinary medicinal product’ laid down in Article 4 of Regulation (EU) 2019/6. Regulation (EU) 2019/6 aims at ensuring a high level of public and animal health and environmental protection. That Regulation stipulates that veterinary medicinal products within its scope can be placed on the market only after a marketing authorisation has been granted. Once a marketing authorisation has been granted, the veterinary medicinal products are also subject to pharmacovigilance. In the case of food-producing species such as honeybees, the pharmacologically active substances included in the medicinal products used need to be allowed in accordance with Regulation (EC) No 470/2009 and any acts adopted on its basis. A withdrawal period is attached to the use of medicinal products in food- producing animals as relevant. There are veterinary medicinal products authorised within the EU with the indication of treatment of Varroa destructor infestations in honeybees and containing, either alone or in combination, active substances referred to in Annex II, Part II, point 1.9.6.3 of Regulation (EU) 2018/848 on organic production and labelling of organic products. Those veterinary medicinal products are to be dispensed in accordance with their classification in accordance with Article 34 and used in accordance with Article 106(1) of Regulation (EU) 2019/6. Only where there are no veterinary medicinal products authorised for the treatment of varroosis or those authorised are not available in a Member State, consideration can be given to use outside the terms of the marketing authorisation in accordance with Article 113. We would like to draw your attention to the established principle that derogations from the Union law governing medicinal products should be interpreted strictly. Best regards, SANTE VETERINARY MEDICINES European Commission Health and Food Safety Directorate General Veterinary Medicines Disclaimer: DG SANTE’s Unit D4 is not in charge of the legal framework setting rules for organic farming. The views expressed above are not legally binding, since only the Court of Justice of the European Union can give an authoritative interpretation of EU law. From: Anne Rath Petersen <[email protected]> Sent: Wednesday, June 28, 2023 8:44 AM To: SANTE VETERINARY MEDICINES <[email protected]> Cc: ZAMORA ESCRIBANO Eva Maria (SANTE) <[email protected]>; Christian Strøyer <[email protected]> Subject: VMP - treatment of Varroa destructor in honey bees Dear colleagues, We hope for your assistance to clarify the following: According to Annex II, Part II, 1.9.6.3, of Regulation 2018/848 on organic production and labelling of organic products formic acid, lactic acid, acetic acid and oxalic acid, as well as menthol, thymol, eucalyptol or camphor, may be used in cases of infestation with Varroa destructor in bees. Would it be in accordance with the VMP Regulation to use the above mentioned substances, which have not been authorised as VMPs, to treat varroa infestation in organic as well as conventional beekeeping? Kind regards, Anne Rath Petersen Special Veterinary Adviser, DVM | Animal Welfare and Veterinary Medicine +45 72 27 69 00 | fvst.dk/contact Ministry of Food, Agriculture and Fisheries The Danish Veterinary and Food Administration | Stationsparken 31-33 | DK 2600 Glostrup | Ph. +45 72 27 69 00 | fvst.dk/contact | www.fvst.dk Appendix 2: REGULATION (EU) 2016/429 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 9 March 2016 on transmissible animal diseases and amending and repealing certain acts in the area of animal health (‘Animal Health Law’) (26) Not all transmissible animal diseases can or should be prevented and controlled through regulatory measures, for example if the disease is too widespread, if diagnostic tools are not available, or if the private sector can take measures to control the disease by itself. Regulatory measures to prevent and control transmissible animal diseases may have important economic consequences for the relevant sectors and may disrupt trade. It is therefore essential that such measures are applied only when they are proportionate and necessary, such as when a disease presents, or is suspected to present, a significant risk to animal or public health. PART III DISEASE AWARENESS, PREPAREDNESS AND CONTROL CHAPTER 2 The use of veterinary medicinal products for disease prevention and control Article 46 The use of veterinary medicinal products for disease prevention and control 1. The Member States may take measures concerning the use of veterinary medicinal products for listed diseases, to ensure the most efficient prevention or control of those diseases, provided that such measures are appropriate or necessary. L 84/54 EN Official Journal of the European Union 31.3.2016 Those measures may cover the following: (a) prohibitions and restrictions on the use of veterinary medicinal products; (b) the compulsory use of veterinary medicinal products. 2. Member States shall take the following criteria into consideration when determining whether or not to use, and how to use, veterinary medicinal products as prevention and control measures for a specific listed disease: (a) the disease profile; (b) the distribution of the listed disease in: (i) the Member State concerned; (ii) the Union; (iii) where relevant, neighbouring third countries and territories; (iv) third countries and territories from which animals and products are brought into the Union; (c) the availability and effectiveness of the veterinary medicinal products in question, and the risks attaching to them; (d) the availability of diagnostic tests for detecting infections in animals treated with the veterinary medicinal products concerned; (e) the economic, social, animal welfare and environmental impact of the use of the veterinary medicinal products concerned compared to other available disease prevention and control strategies. 3. Member States shall take appropriate preventive measures concerning the use of veterinary medicinal products for scientific studies or for the purposes of developing and testing them under controlled conditions to protect animal and public health. Appendix 3: REGULATION (EU) 2018/848 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 30 May 2018 on organic production and labelling of organic products and repealing Council Regulation (EC) No 834/2007 Part II: Livestock production rules 1.9.6. For bees 1.9.6.3. Health care With regard to health care, the following rules shall apply: (a) for the purposes of protecting frames, hives and combs, in particular from pests, only rodenticides used in traps, and appropriate products and substances authorised pursuant to Articles 9 and 24 for use in organic production shall be permitted; (b) physical treatments for disinfection of apiaries such as steam or direct flame shall be permitted; (c) the practice of destroying the male brood shall only be permitted for the purpose of isolating the infestation of Varroa destructor; (d) if, despite all preventive measures, the colonies become sick or infested, they shall be treated immediately and, if necessary, may be placed in isolation apiaries; (e) formic acid, lactic acid, acetic acid and oxalic acid, as well as menthol, thymol, eucalyptol or camphor, may be used in cases of infestation with Varroa destructor; (f) if a treatment is applied with chemically synthesised allopathic products, including antibiotics, other than products and substances authorised pursuant to Articles 9 and 24 for use in organic production, for the duration of that treatment, the treated colonies shall be placed in isolation apiaries and all the wax shall be replaced with wax coming from organic beekeeping. Subsequently, the conversion period of 12 months laid down in point 1.2.2 shall apply to those colonies The Danish Beekeepers Association Over the past several decades the varroa mite has spread all over Europe. This means that beekeepers today operate their beekeeping in such a way that the population of varroa mites is kept low. It is not possible to eliminate the varroa mite like other diseases. It is therefore important that beekeepers have the widest range of options to choose between different operating methods to keep the population of varroa mites under control. If the beekeepers cannot regulate the varroa mite optimally, it will not only cause problems for the beekeeper, but also have secondary consequences for the pollination of agricultural products. In most European countries, beekeepers have a long tradition of varroa control using organic acids in the pure form, following the rules for organic beekeeping. This practice has been developed and adapted over 30 years and beekeepers have been educated in these methods. The experience shows that this practice works well for beekeepers and bees. With reference to article 4 all treatment of varroa must be carried out with registered veterinary medicines for the following reasons: - Honeybees are covered by the law. - The Varroa mite is a parasite and is considered a disease. Since the varroa mite is not a parasite that can be completely controlled in the bee colonies, and therefore must be regulated through operating methods, it is recommended that the control of varroa be exempted from Chapter 4, or at least that beekeepers can use methods based on organic acids in pure form. Only very few registered products on the marked are based on organic acids and these products cannot stand alone. A product can legally only be used as stated in the instruction. Several products have not been tested in more countries and they are not prepared for different conditions and beehives. Varroa control is complicated - multiple treatments are needed. Experience says that we need a varroa strategy, not just individual treatments. There may be a shift towards more use of synthetic pesticides in beekeeping. The organic acids, oxalic acid and formic acid, are found naturally in honey. The acids are pure, naturally occurring substances. Because oxalic acid and formic acid are found naturally in honey, a MRL (Maximum Limit Value) for these acids is not required. The typical treatments with organic acids are carried out after the last honey harvest. The bees that are treated are the generation of so-called winter bees that hatches in August-September. This generation lives 6-7 months and disappear in the early spring after ensuring the wintering of the bee colony. The winter bees are not honey-producing. The acids are applied in several different ways, which enable the beekeeper to use precisely the methods that work best in his or her beekeeping. The effectiveness of the various substances varies with temperature, humidity and the brood situation of the bees. Beehives are treated by evaporation or dripping of the organic acids to achieve a direct contact effect on the varroa mites. There is no need for the treatments to be absorbed into the bees. It is important to emphasize that treatments are only suppressing the mite population. There is no eradication. Organic acids are accepted within organic beekeeping (Annex II, Part II, 1.9.6.3, Letter e of Regulation (EU) 2018/848 of the European Parliament and of the Council of 30 May 2018 on organic production and labeling of organic products and on the repeal of Council Regulation (EC) No. 834/2007). The regulation on organic beekeeping refers to varroa control as health care. Rune Havgaard Sørensen Head of Secretariat Danish Beekeepers Association Fulbyvej 15 - DK-4180 Sorø www.biavl.dk [email protected] Cell. +45 51 30 72 06 FUTURE OPTIONS FOR VARROA CONTROL NBBC – NBARS 21 - 22 March 2024 Regulation EU No 2019/6 article 4: ‘veterinary medicinal product’ means any substance or combination of substances which fulfils at least one of the following conditions: (a) it is presented as having properties for treating or preventing disease in animals; (b) its purpose is to be used in, or administered to, animals with a view to restoring, correcting or modifying physiological functions by exerting a pharmacological, immunological or metabolic action; (c) its purpose is to be used in animals with a view to making a medical diagnosis; (d) its purpose is to be used for euthanasia of animals; Answer from the Commission: • A substance presented as having properties for treating a disease, like varroosis, would meet the definition of ‘veterinary medicinal product’ laid down in Article 4 of Regulation (EU) 2019/6. • Regulation (EU) 2019/6 aims at ensuring a high level of public and animal health and environmental protection. That Regulation stipulates that veterinary medicinal products within its scope can be placed on the market only after a marketing authorisation has been granted. Once a marketing authorisation has been granted, the veterinary medicinal products are also subject to pharmacovigilance. THE BEEKEEPERS: Organic methods with organic acids in pure form. THE COMMISSION: Marketed veterinary medicinal products Legal use of varroa control products NO CHANGES TO THE EU COMMISSION: VARROA IS A DISEASE, LEGISLATION SINCE 2007 LIVESTOCK MAY ONLY BE WHICH MEANS THAT VARROA TREATED WITH MUST BE TREATED WITH MARKETED VETERINARY APPROVED MEDICINES PRODUCTS The challenges of the regulation: • Only very few products based on organic acids are registered and cannot stand alone. • A product can legally only be used as stated in the instruction. Several products have not been tested in more countries and they are not to different conditions and beehives. • Varroa control is complicated - multiple treatments are needed. Experience says that we need a varroa strategy, not just individual treatments. • There may be a shift towards more use of synthetic pesticides in beekeeping. Questionnaire on varroa control Riccardo Pelani 19/12/2023 Policy Advisor WP Honey Questionnaire Are beekeepers allowed to use any varroa treatments (e.g. pure organic acids), or are they obliged to use only products that are registered for varroa control? Nordic-Baltic region FI, SE Yes, they are allowed to use any varroa treatments. DK No, they are obliged to use only products that are registered for varroa control. Mediterranean region IT, ES, PT No, they are obliged to use only products that are registered for varroa control. Western/Central Europe CZ, RO, AT, DE, SK, BE, NL No, they are obliged to use only products that are registered for varroa control. Questionnaire What is the most widespread varroa control practice in your country? Nordic-Baltic region FI, SE, DK Organic methods (e.g., organic acids, thymol). Mediterranean region ES, PT Synthetic varroacides (e.g., amitraz). IT Both organic methods (e.g., organic acids, thymol) and synthetic varroacides (e.g., amitraz). Western/Central Europe AT, NL Organic methods (e.g., organic acids, thymol). CZ, RO, DE, SK, BE, Both organic methods (e.g., organic acids, thymol) and synthetic varroacides. Questionnaire Approximately, how many marketed, registered products are available in your country? Mediterranean region ES 4 synthetic and 5 organic. IT There are at least 15 products registered for Varroasis therapy. The active ingredients many fewer: Oxalic acid, Amitraz, Thymol, Fluvalinate, Flumethrin, Formic acid. PT In Portugal there are 18 veterinary medicines approved for the treatment of varroosis in honeybees with 6 active ingredients. Western/Central Europe AT, RO 18 NL 4 DE 15 SK There is a big number of allowed products, list is on: https://www.svps.sk/zvierata/vcely.asp .But there are just few used widely: Avartin or Varidol (amitraz fumigation strips) Ekopol and Ekovartin strips (with 4 types of essential oils) Formidol pads (with formic acids) Strips with oxalic acid and VarroMed solution. BE 9 Nordic-Baltic region FI In Finland, supply intermediaries have not registered any products as medicinal substances for varroa control. In principle, selective pesticides (such as amitraz, apistan, etc.) or acid-based products could be used if someone were to import them into the country and register them for use in Finland. SE 3 (Apiguard, Apistan, Apivar). DK 2 Godkendte veterinære lægemidler Product Active ingredience Marketed in Denmark Apivar Amitraz - Polyvar Flumethrin - Apiguard Thymol + MaqsPlus Myresyre - Oxybee / Oxalsyre (+) Bienenwohl VarroMed Oxalsyre + Myresyre - Questionnaire If the beekeepers could choose freely, what would be their preferred option for varroa treatment? Nordic-Baltic region FI, SE, DK Organic acids that they mix themselves. Mediterranean region ES, PT Registered products as there is growing concern among beekeepers about the effectiveness and safety of so-called homemade treatments. This concern, and the fact that there is a wide availability and variety of approved veterinary medicines on the market, means that there is no demand (and need) to resort to homemade treatments. IT Both registered products and organic acids that they mix temselves. There is an awareness that the control of the correct use of medicines is a guarantee of the food safety of products and therefore of their quality. However, often in the commercial formulations available on the market there are co-formulants ( sugar, glycerol, water) that make their use not easy. Western/Central Europe AT, DE, SK Registered products with the exception in DE of oxalic acid for sublimation, since it was not registered until September. BE, NL Organic acids that they mix themselves. CZ The beekeepers can choose freely between the authorised veterinary medicine products and their suppliers. There are plenty of preferences between more than 70.000 beekeepers in the country, so it is difficult to pick up a trend. Questionnaire If any, what are the main problems experience by beekeepers for using veterinary medicines for varroa control? Nordic-Baltic region FI Availability: With Apistan, it was observed that the residues in the wax (and also in the honey) increased year by year. Varroa became resistant to the active ingredient in Apistan, and at that point, there was a shift to using natural acids. SE Prices. Mediterranean region ES Lack of effectiveness. PT, IT Prices. In Italy, to date, there is an excessive gap between free active ingredients (see oxalic acid) and their registered commercial formulations. This situation is a critical issue that limits the widespread use of registered products. The fight against varroa has a non marginal impact on the costs of maintaining the hive. The availability of health products on the market is generally not problematic, currently there is no need for veterinary prescription. A problem is also posed by the inadequacy of the formulations on the market, e.g. the only product authorised for sublimation is inadequate due to its sugar content. Western/Central Europe AT, DE Prices. In Germany, hardly any medicament needs an prescription. They are all available. There is no shortage. The prices of the medicaments can be reduced when buying them e.g. via the beekeeping club due to subventions. But the prices might be one reason why some prefer to use unregsitered products such as technical formic acid. BE, RO Prices and availability. NL Prices, need for prescription. CZ Their efficacy in controlling the varroa mite, their mode of use (more or less work and disturbance of the colony), then the price. The Danish Beekeepers' Association focus: - that veterinary medicines based on organic acids and thymol are marketed in Denmark, which give beekeepers the best future options for varroa control, and preferably methods that are as close to current practice as possible - in cooperation with other countries to continue the political process and challenge the EU's regulations, so that beekeepers have the best possible conditions for varroa control Aiming to get the following approvals in Denmark, Sweden, Norway and Finland: • Varroxal, for dripping, spraying and vaporizing • Varroxal 0.71g/g beehive powder • Thymovar • FORMIVAR® 60 and 85 Still checking the possibility of integrating for Denmark (In Germany only 60% is approved at the moment) How long this will take and how quickly it will happen is now an open question. EVALUATION Deadline: 3rd of April https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/14036-Animal-Health-Law-evaluation_en Thank you
Allikas: Ravimiamet dokumendiregister →